Taiwan FDA registration 0317580c5c58cde052414e572cd4abd6
Mei Ariel Yazi comprehensive cardiac test reagent
TW: 美艾利爾 揣耶濟 心臟綜合檢測試劑
Taiwan·Risk Class 2·ALERE SAN DIEGO, INC.·Registered Mar 20, 2006 – Mar 20, 2016CancelledRegistration details
- Analysis ID
- 0317580c5c58cde052414e572cd4abd6
- Customs Code
- DHA00601617403
Company information
- Manufacturer
- ALERE SAN DIEGO, INC.
- Manufacturer Country
- United States
- Authorized Representative
- Ariel Health Inc
Product details
- Intended Use
- 利用螢光免疫法,在Triage機器定量檢測人類EDTA全血或血漿中CK-MB、Myoglobin、Troponin I、BNP濃度.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1117 B type B natriuretic peptide test system
- Import Information
- import
Dates and status
- Registration Date
- Mar 20, 2006
- Expiry Date
- Mar 20, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Mei Ariel Yazi comprehensive cardiac test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0317580c5c58cde052414e572cd4abd6 and manufactured by ALERE SAN DIEGO, INC.. The authorized representative in Taiwan is Ariel Health Inc.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices